SCHEMBL29633599

SCHEMBL29633599

CCOP(=O)(OCC)C(c1ccccc1)c1ccccc1O

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.58
PTPN2 P17706 1/20 0.52
PTPN1 P18031 1/20 0.52
MAPT P10636 4/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
KDM4E B2RXH2 1/20 0.44
ACP3 P15309 1/20 0.43
TSHR P16473 2/20 0.43
MAPK1 P28482 2/20 0.43
PTPN9 P43378 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23372828 1.00 POLB (0.58) POLBPTPN2PTPN1MAPTALDH1A1
SCHEMBL23357394 0.92 POLB (0.49) POLBPTPN2PTPN1MAPTALDH1A1
SCHEMBL23357398 0.90 PTPN2 (0.49) POLBPTPN2PTPN1MAPTALDH1A1
SCHEMBL23357439 0.89 PTPN2 (0.48) POLBPTPN2PTPN1MAPTALDH1A1
SCHEMBL23357559 0.89 ALDH1A1 (0.50) POLBPTPN2PTPN1ALDH1A1LMNA
SCHEMBL23373031 0.88 MEN1 (0.47) POLBPTPN2PTPN1MAPTALDH1A1
SCHEMBL26999466 0.87 POLB (0.49) POLBPTPN2PTPN1MAPTALDH1A1
SCHEMBL26999472 0.87 POLB (0.49) POLBPTPN2PTPN1MAPTALDH1A1
SCHEMBL26999469 0.87 POLB (0.49) POLBPTPN2PTPN1MAPTALDH1A1
SCHEMBL26999470 0.87 POLB (0.49) POLBPTPN2PTPN1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873315-B2 Chiral n-heterocyclic phosphorodiamidic acids (NHPAS) and derivatives as novel Brønsted acid catalysts THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS (US) 2024-01-16 US disclosed
US-20220144868-A1 CHIRAL N-HETEROCYCLIC PHOSPHORODIAMIDIC ACIDS (NHPAS) AND DERIVATIVES AS NOVEL BRONSTED ACID CATALYSTS The Board of Regents of the Nevada System of Higher Education on Behalf of the Univ of Nevada (US) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11873315-B2 Chiral n-heterocyclic phosphorodiamidic acids (NHPAS) and derivatives as novel Brønsted acid catalysts ELANE, PNKP, SERPINB1 POLB 1316/4885PTPN2 2417/4885PTPN1 1847/4885
US-20220144868-A1 CHIRAL N-HETEROCYCLIC PHOSPHORODIAMIDIC ACIDS (NHPAS) AND DERIVATIVES AS NOVEL BRONSTED ACID CATALYSTS ELANE, PNKP, NHERF1 POLB 1299/4885PTPN2 2105/4885PTPN1 1429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.